These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22678129)

  • 1. Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.
    Chi OZ; Barsoum S; Grayson J; Hunter C; Liu X; Weiss HR
    Pharmacology; 2012; 89(5-6):333-8. PubMed ID: 22678129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.
    Muthian S; Rademacher DJ; Roelke CT; Gross GJ; Hillard CJ
    Neuroscience; 2004; 129(3):743-50. PubMed ID: 15541895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex.
    Chi OZ; Hunter C; Liu X; Weiss HR
    Neurol Res; 2005 Dec; 27(8):864-8. PubMed ID: 16354548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SR141716 and WIN 55,212-2 on tolerance to ethanol in rats using the acute and rapid procedures.
    Lemos JI; Takahashi RN; Morato GS
    Psychopharmacology (Berl); 2007 Oct; 194(2):139-49. PubMed ID: 17546513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat.
    Yüce B; Kemmer M; Qian G; Müller M; Sibaev A; Li Y; Kreis ME; Storr M
    Neurogastroenterol Motil; 2010 Jun; 22(6):672-e205. PubMed ID: 20158615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A.
    Pozzi O; Misiano P; Clark GD; Visentin L
    Pharmacology; 2003 Nov; 69(3):158-63. PubMed ID: 14512703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures.
    Antonelli T; Tomasini MC; Tattoli M; Cassano T; Finetti S; Mazzoni E; Trabace L; Carratù MR; Cuomo V; Tanganelli S; Ferraro L
    Neurochem Int; 2006 Nov; 49(6):568-76. PubMed ID: 16777266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia.
    Chi OZ; Hunter C; Liu X; Chi Y; Weiss HR
    J Neurol Sci; 2011 Feb; 301(1-2):66-70. PubMed ID: 21094956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity.
    Lever IJ; Pheby TM; Rice AS
    Br J Pharmacol; 2007 May; 151(2):292-302. PubMed ID: 17375083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood -brain barrier disruption was less under isoflurane than pentobarbital anesthesia via a PI3K/Akt pathway in early cerebral ischemia.
    Chi OZ; Mellender SJ; Kiss GK; Liu X; Weiss HR
    Brain Res Bull; 2017 May; 131():1-6. PubMed ID: 28238830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.
    Fukuda H; Abe T; Yoshihara S
    Int Arch Allergy Immunol; 2010; 152(3):295-300. PubMed ID: 20150748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.
    Manzanedo C; Rodríguez-Arias M; Daza-Losada M; Maldonado C; Aguilar MA; Miñarro J
    Behav Brain Funct; 2010 Mar; 6():19. PubMed ID: 20307280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex.
    Page ME; Oropeza VC; Van Bockstaele EJ
    Neurosci Lett; 2008 Jan; 431(1):1-5. PubMed ID: 18055114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors.
    Hampson RE; Sweatt AJ; Goonawardena AV; Song D; Chan RH; Marmarelis VZ; Berger TW; Deadwyler SA
    Behav Pharmacol; 2011 Aug; 22(4):335-46. PubMed ID: 21558844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY; D'Agostino B; Risse PA; Marrocco G; Naline E; Zhang Y; Chen HZ; Finance O; Rinaldi-Carmona M; Rossi F; Advenier C
    Eur J Pharmacol; 2007 Nov; 573(1-3):206-13. PubMed ID: 17643417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.
    Martín-García E; Burokas A; Martín M; Berrendero F; Rubí B; Kiesselbach C; Heyne A; Gispert JD; Millán O; Maldonado R
    J Neurochem; 2010 Mar; 112(5):1338-13351. PubMed ID: 20028452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
    Fattore L; Spano M; Melis V; Fadda P; Fratta W
    Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms.
    Hough LB; Svokos K; Nalwalk JW
    Brain Res; 2009 Jan; 1247():62-70. PubMed ID: 18983834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.